Filter
45
Filtered Results: 45
Text search:
nanoparticles
Featured
Recommendations
9
New Publications
5
Language
Document type
Guidelines
14
Studies & Reports
13
No document type
10
Manuals
4
Fact sheets
4
Countries / Regions
Syria
3
Middle East and North Africa
3
Russia
3
Yemen
3
Ukraine
1
Global
1
Latin America and the Carribbean
1
Sudan
1
South Sudan
1
Authors & Publishers
Publication Years
Category
COVID-19
6
Guidelines
3
Pharmacy & Technology
1
Child Health
1
Pediatrics
1
Hemorrhagic Fever
1
Studies & Reports
1
Parasitology
1
Laboratory Quality Assurance
1
Malaria
1
Toolboxes
PPE Personel Protective Equipment
8
Research
3
Medical & Community Masks
3
Biontech/Pfizer Comirnaty
3
Inactivated COVID-19 Vaccines
3
Clean air
3
Treatment Guidelines
2
Planetary Health
2
Essential Medicines
2
Local Action
1
Laboratory Guidance
1
Agriculture & Veterinary
1
Clinical Aspects, Treatment & Prevention
1
Health Equity & Equality
1
Climate & Health
1
Diagnostics & Laboratory Guidance
1
For Health Worker
1
Clinical Guidelines
1
Country specific documents
1
Global Impact: Socio-economic, health services, TB & HIV
1
Hospital Readiness/Essential Health Services
1
Access & Strategy
1
Presentation
1
Logistics & Supply
1
Moderna
1
Vaxzevria (Astra Zeneca)
1
Sputnik V
1
Research & Pipeline
1
Reports
1
Prices and Patents
1
Rational use of Medicine
1
General documents One Health
1
Pharmacovigilance
1
Guidelines & Manuals
1
MPOX - Monkeypox
1
Studies & Reports
1
Studies & Reports
1
Detection & Diagnosis
1
Human Rights & the Right to Health
1
Clinical Guidelines
1
Antiretroviral Treatment ART
1
Laboratory & Diagnostics
1
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Presentation is current through November 21, 2014 and will be updated every Friday by 5pm. For the most up-to-date information, please visit www.cdc.gov/ebola.
*Presentation contains materials from CDC, MSF, and WHO
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i...
Les messages clés pour des actions concrètes présentés ci-après résument un
ensemble de chapitres sur différents problèmes de santé liés à l’environnement,
qui peuvent être consultés à l’adresse suivante: www.who.int/ceh/publications/
healthyenvironmentsforhealthychildren.
